Escalon Medical Statistics
Total Valuation
Escalon Medical has a market cap or net worth of 3.40 million. The enterprise value is 4.02 million.
Market Cap | 3.40M |
Enterprise Value | 4.02M |
Important Dates
The last earnings date was Thursday, May 15, 2025.
Earnings Date | May 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Escalon Medical has 7.42 million shares outstanding. The number of shares has increased by 68.28% in one year.
Current Share Class | 7.42M |
Shares Outstanding | 7.42M |
Shares Change (YoY) | +68.28% |
Shares Change (QoQ) | +0.60% |
Owned by Insiders (%) | 6.24% |
Owned by Institutions (%) | n/a |
Float | 6.81M |
Valuation Ratios
The trailing PE ratio is 9.58.
PE Ratio | 9.58 |
Forward PE | n/a |
PS Ratio | 0.26 |
PB Ratio | 1.48 |
P/TBV Ratio | 2.10 |
P/FCF Ratio | 214.40 |
P/OCF Ratio | 135.39 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.88, with an EV/FCF ratio of 253.55.
EV / Earnings | 11.31 |
EV / Sales | 0.31 |
EV / EBITDA | 3.88 |
EV / EBIT | 6.25 |
EV / FCF | 253.55 |
Financial Position
The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.23.
Current Ratio | 1.92 |
Quick Ratio | 1.06 |
Debt / Equity | 0.23 |
Debt / EBITDA | 0.50 |
Debt / FCF | 32.59 |
Interest Coverage | 34.57 |
Financial Efficiency
Return on equity (ROE) is 31.22% and return on invested capital (ROIC) is 15.76%.
Return on Equity (ROE) | 31.22% |
Return on Assets (ROA) | 8.19% |
Return on Invested Capital (ROIC) | 15.76% |
Return on Capital Employed (ROCE) | 23.85% |
Revenue Per Employee | 323,697 |
Profits Per Employee | 8,884 |
Employee Count | 40 |
Asset Turnover | 2.64 |
Inventory Turnover | 3.99 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +146.69% in the last 52 weeks. The beta is 0.08, so Escalon Medical's price volatility has been lower than the market average.
Beta (5Y) | 0.08 |
52-Week Price Change | +146.69% |
50-Day Moving Average | 0.23 |
200-Day Moving Average | 0.17 |
Relative Strength Index (RSI) | 66.66 |
Average Volume (20 Days) | 41,239 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.14 |
Income Statement
In the last 12 months, Escalon Medical had revenue of 12.95 million and earned 355,374 in profits. Earnings per share was 0.05.
Revenue | 12.95M |
Gross Profit | 5.86M |
Operating Income | 643,289 |
Pretax Income | 619,682 |
Net Income | 355,374 |
EBITDA | 691,808 |
EBIT | 643,289 |
Earnings Per Share (EPS) | 0.05 |
Balance Sheet
The company has 540,908 in cash and 516,461 in debt, giving a net cash position of 24,447 or 0.00 per share.
Cash & Cash Equivalents | 540,908 |
Total Debt | 516,461 |
Net Cash | 24,447 |
Net Cash Per Share | 0.00 |
Equity (Book Value) | 2.29M |
Book Value Per Share | 0.22 |
Working Capital | 2.32M |
Cash Flow
In the last 12 months, operating cash flow was 25,094 and capital expenditures -9,247, giving a free cash flow of 15,847.
Operating Cash Flow | 25,094 |
Capital Expenditures | -9,247 |
Free Cash Flow | 15,847 |
FCF Per Share | 0.00 |
Margins
Gross margin is 45.25%, with operating and profit margins of 4.97% and 4.79%.
Gross Margin | 45.25% |
Operating Margin | 4.97% |
Pretax Margin | 4.79% |
Profit Margin | 4.79% |
EBITDA Margin | 5.34% |
EBIT Margin | 4.97% |
FCF Margin | 0.12% |
Dividends & Yields
Escalon Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -68.28% |
Shareholder Yield | n/a |
Earnings Yield | 10.46% |
FCF Yield | 0.47% |
Stock Splits
The last stock split was on November 24, 1997. It was a reverse split with a ratio of 0.25.
Last Split Date | Nov 24, 1997 |
Split Type | Reverse |
Split Ratio | 0.25 |
Scores
Escalon Medical has an Altman Z-Score of -14.6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -14.6 |
Piotroski F-Score | n/a |